157 related articles for article (PubMed ID: 28624580)
1. Proton Pump Inhibitors Decrease Phlebotomy Need in HFE Hemochromatosis: Double-Blind Randomized Placebo-Controlled Trial.
Vanclooster A; van Deursen C; Jaspers R; Cassiman D; Koek G
Gastroenterology; 2017 Sep; 153(3):678-680.e2. PubMed ID: 28624580
[TBL] [Abstract][Full Text] [Related]
2. Proton Pump Inhibitors Reduce the Frequency of Phlebotomy in Patients With Hereditary Hemochromatosis.
van Aerts RM; van Deursen CT; Koek GH
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):147-52. PubMed ID: 26240005
[TBL] [Abstract][Full Text] [Related]
3. The modified iron avidity index: a promising phenotypic predictor in HFE-related haemochromatosis.
Verhaegh PL; Moris W; Koek GH; van Deursen CT
Liver Int; 2016 Oct; 36(10):1535-9. PubMed ID: 26992127
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors reduce phlebotomy burden in patients with HFE-related hemochromatosis: a systematic review and meta-analysis.
Dirweesh A; Anugwom CM; Li Y; Vaughn BP; Lake J
Eur J Gastroenterol Hepatol; 2021 Oct; 33(10):1327-1331. PubMed ID: 32769410
[TBL] [Abstract][Full Text] [Related]
5. GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
Levstik A; Stuart A; Adams PC
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis.
Hutchinson C; Geissler CA; Powell JJ; Bomford A
Gut; 2007 Sep; 56(9):1291-5. PubMed ID: 17344278
[TBL] [Abstract][Full Text] [Related]
7. Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial.
Rombout-Sestrienkova E; Nieman FH; Essers BA; van Noord PA; Janssen MC; van Deursen CT; Bos LP; Rombout F; van den Braak R; de Leeuw PW; Koek GH
Transfusion; 2012 Mar; 52(3):470-7. PubMed ID: 21848963
[TBL] [Abstract][Full Text] [Related]
8. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
Kowdley KV; Modi NB; Peltekian K; Vierling JM; Ferris C; Valone FH; Gupta S
Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1118-1128. PubMed ID: 37863080
[TBL] [Abstract][Full Text] [Related]
9. HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women.
Warne CD; Zaloumis SG; Bertalli NA; Delatycki MB; Nicoll AJ; McLaren CE; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ; Gurrin LC;
J Gastroenterol Hepatol; 2017 Apr; 32(4):797-802. PubMed ID: 27784128
[TBL] [Abstract][Full Text] [Related]
10. Absorption of nonheme iron during gastric acid suppression in patients with hereditary hemochromatosis and healthy controls.
Moris W; Verhaegh PLM; Verbeek J; Swinkels DW; Laarakkers CM; Masclee AAM; Koek GH; Deursen CTBMV
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1105-G1110. PubMed ID: 33949198
[TBL] [Abstract][Full Text] [Related]
11. Relationship of Baseline Hemoglobin Level with Serum Ferritin, Postphlebotomy Hemoglobin Changes, and Phlebotomy Requirements among HFE C282Y Homozygotes.
Mousavi SA; Mahmood F; Aandahl A; Knutsen TR; Llohn AH
Biomed Res Int; 2015; 2015():241784. PubMed ID: 26380265
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype.
Adams P; Altes A; Brissot P; Butzeck B; Cabantchik I; Cançado R; Distante S; Evans P; Evans R; Ganz T; Girelli D; Hultcrantz R; McLaren G; Marris B; Milman N; Nemeth E; Nielsen P; Pineau B; Piperno A; Porto G; Prince D; Ryan J; Sanchez M; Santos P; Swinkels D; Teixeira E; Toska K; Vanclooster A; White D;
Hepatol Int; 2018 Mar; 12(2):83-86. PubMed ID: 29589198
[TBL] [Abstract][Full Text] [Related]
13. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
[TBL] [Abstract][Full Text] [Related]
14. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
[TBL] [Abstract][Full Text] [Related]
15. A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: a follow-up study.
Milet J; Le Gac G; Scotet V; Gourlaouen I; Thèze C; Mosser J; Bourgain C; Deugnier Y; Férec C
Blood Cells Mol Dis; 2010 Jan; 44(1):34-7. PubMed ID: 19879168
[TBL] [Abstract][Full Text] [Related]
16. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.
Desgrippes R; Lainé F; Morcet J; Perrin M; Manet G; Jezequel C; Bardou-Jacquet E; Ropert M; Deugnier Y
Hepatology; 2013 May; 57(5):1784-92. PubMed ID: 23322654
[TBL] [Abstract][Full Text] [Related]
17. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
Barton JC; Barton EH; Acton RT
BMC Med Genet; 2006 Mar; 7():22. PubMed ID: 16533407
[TBL] [Abstract][Full Text] [Related]
18. Do pregnancies reduce iron overload in HFE hemochromatosis women? results from an observational prospective study.
Scotet V; Saliou P; Uguen M; L'Hostis C; Merour MC; Triponey C; Chanu B; Nousbaum JB; Le Gac G; Ferec C
BMC Pregnancy Childbirth; 2018 Feb; 18(1):53. PubMed ID: 29454332
[TBL] [Abstract][Full Text] [Related]
19. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
[TBL] [Abstract][Full Text] [Related]
20. [Hereditary hemochromatosis: molecular diagnosis and effect of treatment].
Szczeklik W; Dropiński J; Dziedzina S; Szułdrzyński K; Biesiada G; Mach T; Sanak M
Pol Arch Med Wewn; 2004 May; 111(5):593-6. PubMed ID: 15508811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
